CALL (210) 567-4655
  • ARTT
  • FINDING TREATMENT
  • BBC
  • T32
logo
  • BBC
    Home
  • 2023
    Meeting
    2023 Meeting Details Conference Registration Travel Awards Abstracts Hotel Information
  • PCS
    Workshop
  • Additional
    Information
    Code of Conduct Presentation Tips Previous Meetings Conference Publications
  • BBC
    Contact
  • BBC Publications

  • 2016
    Glial and neuroinflammatory targets for treating substance use disorders.

    Bachtell RK, Jones JD, Heinzerling KG, Beardsley PM, Comer SD. (2017) Glial and neuroinflammatory targets for treating substance use disorders. Drug and Alcohol Dependence Nov 1;180:156-170. doi: 10.1016/j.drugalcdep.2017.08.003. Epub 2017 Aug 31.

  • 2015
    Behavioral, biological and chemical perspectives on atypical agents targeting the dopamine transporter.

    Reith, ME., Blough, BE., Hong, WC., Jones, KT., Schmitt, KC., Baumann, MH., Partilla, JS., Rothman, RB. and Katz, JL. (2015) Behavioral, biological and chemical perspectives on atypical agents targeting the dopamine transporter. Drug and Alcohol Dependence Feb 1;147C:1-19. doi: 10.1016/j.drugalcdep.2014.12.005. Epub 2014 Dec 18

  • 2014
    Scientific overview: 2013 BBC plenary symposium on tobacco addiction.

    De Biasi, M., McLaughlin, I., Perez, EE., Crooks, PA., Dwoskin, LP., Bardo, MT., Pentel, PR. and Hatsukami, D. (2014) Scientific overview: 2013 BBC plenary symposium on tobacco addiction. Drug and Alcohol Dependence Aug 1;141:107-17. doi: 10.1016/j.drugalcdep.2014.05.013. Epub 2014 Jun 2. Erratum in: Drug Alcohol Depend. 2014 Nov 1;144:290

  • 2013
    Behavioral, biological, and chemical perspectives on targeting CRF1 receptor antagonists to treat alcoholism.

    Zorrilla, EP., Heilig, M., de Wit, H. and Shaham, Y. (2013) Behavioral, biological, and chemical perspectives on targeting CRF1 receptor antagonists to treat alcoholism. Drug and Alcohol Dependence Mar 1;128(3):175-86. doi: 10.1016/j.drugalcdep.2012.12.017. Epub 2013 Jan 5

  • 2012
    Antinociceptive effects of herkinorin, a MOP receptor agonist derived from salvinorin A in the formalin test in rats: New concepts in mu opioid receptor pharmacology: From a symposium on new concepts in mu-opioid pharmacology.

    Lamb, K., Tidgewell, K., Simpson, DS., Bohn, LM. and Prisinzano, TE. (2012) Antinociceptive effects of herkinorin, a MOP receptor agonist derived from salvinorin A in the formalin test in rats: New concepts in mu opioid receptor pharmacology: From a symposium on new concepts in mu-opioid pharmacology. Drug and Alcohol Dependence Mar 1;121(3):181-8. doi: 10.1016/j.drugalcdep.2011.10.026. Epub 2011 Nov 26

  • 2012
    Examining the role of mu opioid receptor endocytosis in the beneficial and side-effects of prolonged opioid use: From a symposium on new concepts in mu-opioid pharmacology.

    Whistler, JL. (2012) Examining the role of mu opioid receptor endocytosis in the beneficial and side-effects of prolonged opioid use: From a symposium on new concepts in mu-opioid pharmacology. Drug and Alcohol Dependence Mar 1;121(3):189-204. doi: 10.1016/j.drugalcdep.2011.10.031. Epub 2012 Jan 9

  • 2012
    Functional relevance of μ-δ opioid receptor heteromerization: A Role in novel signaling and implications for the treatment of addiction disorders: From a symposium on new concepts in mu-opioid pharmacology.

    Stockton, SD. and Jr, Devi, LA. (2012) Functional relevance of μ-δ opioid receptor heteromerization: A Role in novel signaling and implications for the treatment of addiction disorders: From a symposium on new concepts in mu-opioid pharmacology. Drug and Alcohol Dependence Mar 1;121(3):167-72. doi: 10.1016/j.drugalcdep.2011.10.025. Epub 2011 Nov 23

  • 2012
    μ-Opioid receptors and regulators of G protein signaling (RGS) proteins: From a symposium on new concepts in mu-opioid pharmacology.

    Traynor, J. (2012) μ-Opioid receptors and regulators of G protein signaling (RGS) proteins: From a symposium on new concepts in mu-opioid pharmacology. Drug and Alcohol Dependence Mar 1;121(3):173-80. doi: 10.1016/j.drugalcdep.2011.10.027. Epub 2011 Nov 29

Funding for this conference is made possible [in part] by R13 DA029347 from The National Institute on Drug Abuse (NIDA). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

logo
  • 7703 Floyd Curl Drive,
    Mail Code 7764,
    San Antonio, TX 78229
  • +1 (210) 567-4655
  • bbc@uthscsa.edu

ARTT
Center

  • ARTT Home
  • ARTT Leadership
  • Contact
  • News

BBC Conference

  • Program
  • Registration
  • Abstract Guidelines
  • PCS Workshops

T32 Training Program

  • Current Trainees
  • Training
  • Training Faculty
  • Open Positions

Finding
Treatment

  • TxMOUD
  • Be Well Clinic
  • Texas Substance Use Symposium

Copyright ©
Disclaimer: Links from Health Science Center pages to other web sites do not constitute or imply an endorsement of those sites, their content, or products and services associated with those sites.